Metropolitan Life Insurance Company (MetLife)’s UserTesting, Inc. USER Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio USER Stock Details USER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,354	Closed	-$25.2K	–	2530
2022 Q4	$25.2K	Buy	+3,354	New	+$21.5K	﹤0.01%	1879
2022 Q3	–	Sell	-3,240	Closed	-$16.3K	–	2384
2022 Q2	$16.3K	Buy	+3,240	New	+$21.8K	﹤0.01%	2142

Metropolitan Life Insurance Company (MetLife)'s USER Position: Q1 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of UserTesting, Inc. (USER) in Q1 2023, closing a stake of 3,354 shares — an estimated $25.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in USER in Q2 2022 and held it in 2 quarters. The position peaked at $25.2K in Q4 2022. 0 funds tracked by Wall St. Rank hold USER as of Q1 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining UserTesting, Inc. position as of Q1 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 3,354 UserTesting, Inc. shares in Q1 2023, an estimated $25.2K.
Metropolitan Life Insurance Company (MetLife) first reported a position in UserTesting, Inc. in Q2 2022 and held it in 2 quarters.
Metropolitan Life Insurance Company (MetLife)'s UserTesting, Inc. position peaked at $25.2K in Q4 2022.
0 funds tracked by Wall St. Rank held UserTesting, Inc. as of Q1 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.